BusinessSPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and DevelopmentBy Nasdaq OMXSep 7, 2017, 1:13 PM UTC
BusinessOpioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement SurgeryBy Nasdaq OMXAug 3, 2017, 3:03 PM UTC
BusinessSPR Therapeutics Appoints Michael P. Chuisano to Board of DirectorsBy Nasdaq OMXMar 21, 2017, 1:33 PM UTC
BusinessChronic Pain: Third Indication Approved by Brazilian Government for Medical Marijuana Inc.’s Real Scientific Hemp Oil™ (RSHO™)By Nasdaq OMXDec 8, 2015, 2:53 PM UTC
